Cyclacel Pharmaceuticals, Inc. (CYCC) Posts Q3 Loss of 32c/Share
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
